HCM
TMO icon

HMS Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

HMS Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,546
Closed -$821K – 124
2023
Q4 		$821K Sell
1,546
-103
-6% -$49.9K 0.5% 46
2023
Q3 		$835K Sell
1,649
-97
-6% -$51.7K 0.55% 48
2023
Q2 		$911K Sell
1,746
-336
-16% -$181K 0.55% 46
2023
Q1 		$1.2M Buy
2,082
+1,129
+118% +$636K 0.76% 36
2022
Q4 		$525K Sell
953
-392
-29% -$208K 0.3% 55
2022
Q3 		$682K Sell
1,345
-66
-5% -$36.9K 0.41% 55
2022
Q2 		$767K Sell
1,411
-4,218
-75% -$2.32M 0.39% 54
2022
Q1 		$3.33M Sell
5,629
-50
-0.9% -$28.7K 1.39% 14
2021
Q4 		$3.79M Sell
5,679
-231
-4% -$144K 1.65% 13
2021
Q3 		$3.38M Sell
5,910
-345
-6% -$189K 1.59% 15
2021
Q2 		$3.16M Buy
6,255
+86
+1% +$40.6K 1.42% 17
2021
Q1 		$2.81M Sell
6,169
-960
-13% -$458K 1.19% 15
2020
Q4 		$3.32M Sell
7,129
-109
-2% -$51.1K 1.51% 11
2020
Q3 		$3.19M Sell
7,238
-355
-5% -$147K 1.24% 13
2020
Q2 		$2.75M Buy
7,593
+3,309
+77% +$1.11M 1.21% 17
2020
Q1 		$1.22M Sell
4,284
-2,225
-34% -$702K 1.18% 21
2019
Q4 		$2.12M Sell
6,509
-107
-2% -$32.4K 0.89% 24
2019
Q3 		$1.93M Sell
6,616
-188
-3% -$53.8K 0.72% 34
2019
Q2 		$2M Sell
6,804
-518
-7% -$143K 0.86% 25
2019
Q1 		$2M Buy
7,322
+868
+13% +$216K 0.85% 30
2018
Q4 		$1.44M Buy
+6,454
New +$1.51M 0.73% 36

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

HMS Capital Management's TMO Position: Q1 2024 in Review

HMS Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2024, closing a stake of 1,546 shares — an estimated $821K sold.

HMS Capital Management first reported a position in TMO in Q4 2018 and held it in 21 quarters. The position peaked at $3.79M in Q4 2021. 2,527 funds tracked by Wall St. Rank hold TMO as of Q1 2024.

  • HMS Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2024 after selling out during the quarter.
  • HMS Capital Management sold 1,546 Thermo Fisher Scientific shares in Q1 2024, an estimated $821K.
  • HMS Capital Management first reported a position in Thermo Fisher Scientific in Q4 2018 and held it in 21 quarters.
  • HMS Capital Management's Thermo Fisher Scientific position peaked at $3.79M in Q4 2021.
  • 2,527 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2024.

Based on HMS Capital Management's 13F filing for Q1 2024, filed 24 Apr 2024.